The study aimed at evaluating the integration into everyday care of an electronic health solution, www.young.constant-care.com (I-eHealth). In non biological therapies, patients ages 10 to 17 were offered the I-eHealth solution...
Although in children with higher anti-transglutaminase (TGA-IgA) titres, the algorithm of the diagnosis of celiac disease (CD) is well known, it is a clinical challenge to handle children with low TGA-IgA levels. The study aimed...
The objective of the study was to conduct a thorough evaluation of studies into the link between celiac and autistic spectrum disorders (ASD). MEDLINE and EMBASE’s literature search was conducted with no year or linguistic...
Movicol (polyethylène glycol 3350 with electrolytes [PEG 3350+E], Norgine, UK) is authorised in the United Kingdom for chronic constipation in children aged 2-11 and 5 years of age for faecal impaction (FI). The purpose of this...
Random colonic biopsies even from ordinary tissue are currently performed during paediatric colonoscopy. The majority of published material on colonic biopsy studies adults; however, the paediatric population is examined only by...
Although several hereditary variations of cholestasis have been identified, in a fraction of cholestasis patients, the genetic aetiology of the condition remains unclear. Full exome sequencing (WES) has been undertaken in DNA...
With the introduction of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel therapy for unresectable pancreatic cancer, erlotinib plus gemcitabine therapy is now occasionally used as late-line therapy. This study...
Constipation is prevalent in pediatric cystic fibrosis patients and colonic motility has not been studied in this population. In this study, we aimed to evaluate the total and segmental colonic transit time in children and...
This study aimed to understand the prevalence of prediabetes (preDM) and diabetes mellitus (DM) in patients with cancer overall and by tumor site, cancer treatment, and time point in the cancer continuum.This cohort study was...
Gender-related differences in COVID-19 clinical presentation, disease progression, and mortality have not been adequately explored. We analyzed the clinical profile, presentation, treatments, and outcomes of patients according...
Chemotherapy is well documented to disrupt the gut microbiome, leading to poor treatment outcomes and a heightened risk of adverse toxicity. Although strong associations exist between its composition and gastrointestinal...
25 years ago the field was revolutionized by the introduction of infliximab as the first hybrid anti-TNF-antibody. Subsequently, other humanized anti-TNFs were developed and marketed, followed by antibodies to new targets...
